Adam J. Townsend is CCO at Apellis Pharmaceuticals, Inc. (APLS). They have made 20 open-market trades across 1 company since 2022, most recently 2025-01-29.
CIK 0001773588
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 20 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| APLS | 84,050 | $3.4M |
Shares reported on the most recent Form 4, priced at the 2025-01-30 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| APLS | SELL | 2025-01-29 | 2025-01-30 | $29.52 | $21K | -5.8% | -20.6% | -36.6% |
| APLS | SELL | 2025-01-22 | 2025-01-23 | $30.43 | $202K | -6.4% | -10.8% | -43.1% |
| APLS | SELL | 2025-01-17 | 2025-01-21 | $29.96 | $132K | -3.4% | -5.6% | -39.9% |
| APLS | SELL | 2025-01-13 | 2025-01-14 | $28.70 | $154K | +5.2% | -3.1% | -31.8% |
| APLS | SELL | 2024-02-12 | 2024-02-13 | $67.77 | $156K | +7.0% | -15.8% | -35.8% |
| APLS | SELL | 2024-01-29 | 2024-01-31 | $64.14 | $116K | +6.8% | +0.7% | -30.4% |
| APLS | SELL | 2024-01-22 | 2024-01-23 | $65.00 | $222K | -6.3% | +1.3% | -28.6% |
| APLS | SELL | 2024-01-16 | 2024-01-17 | $66.81 | $299K | -1.8% | +3.3% | -22.2% |
| APLS | SELL · 10b5-1 | 2023-12-01 | 2023-12-05 | $60.81 | $13.4M | -18.7% | -6.3% | -0.3% |
| APLS | SELL · 10b5-1 | 2023-05-03 | 2023-05-04 | $82.71 | $827K | -5.2% | -2.9% | -74.1% |
| APLS | SELL · 10b5-1 | 2023-04-03 | 2023-04-05 | $74.05 | $370K | +6.2% | +20.4% | +14.1% |
| APLS | SELL | 2023-03-03 | 2023-03-07 | $63.84 | $319K | -1.2% | +23.5% | +40.8% |
| APLS | SELL | 2023-02-03 | 2023-02-06 | $55.85 | $279K | -6.1% | +17.1% | +65.2% |
| APLS | SELL | 2023-01-03 | 2023-01-05 | $50.70 | $254K | +7.3% | +15.2% | +61.4% |
| APLS | SELL | 2022-12-05 | 2022-12-07 | $50.38 | $252K | +9.1% | -2.3% | +34.2% |
| APLS | SELL | 2022-11-03 | 2022-11-07 | $58.54 | $293K | -7.0% | +2.3% | +18.8% |
| APLS | SELL | 2022-10-03 | 2022-10-05 | $66.69 | $333K | +2.1% | -11.8% | -12.1% |
| APLS | SELL | 2022-09-06 | 2022-09-07 | $60.38 | $302K | -0.3% | -9.0% | -26.7% |
| APLS | SELL | 2022-08-15 | 2022-08-16 | $69.00 | $863K | -17.9% | -4.8% | -31.1% |
| APLS | SELL | 2022-08-11 | 2022-08-12 | $67.00 | $838K | -9.1% | +0.1% | -32.9% |
| APLS | SELL | 2022-08-08 | 2022-08-09 | $65.00 | $813K | +0.4% | +5.9% | -26.4% |
| APLS | SELL | 2022-08-03 | 2022-08-04 | $56.43 | $282K | +12.3% | -4.7% | -2.7% |
| APLS | SELL | 2022-07-11 | 2022-07-12 | $48.42 | $242K | +12.0% | +38.9% | +22.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.